Assessment of COVID-19 Vaccine Effectiveness Against SARS-CoV-2 Infection, Hospitalization and Death in Mexican Patients with Metabolic Syndrome from Northeast Mexico: A Multicenter Study.

Finally, an analysis of COVID-19 vaccine effectiveness against death was performed in patients with two doses and this demonstrated that BO, only BNT162b2 significantly protects patients with metabolic syndrome against death whereas ChAdOx1 and CoronaVac failed to reach significance.

also in 4,113 other papers

Vaccine Effectiveness Against Death in Patients with Metabolic Syndrome A similar analysis was performed for death, where BO, one dose of CoronaVac showed 100% protection against death whereas the ChAdOx1 and BNT162b2 vaccines only showed a trend toward protection against death.

also in 53,322 other papers